Press Releases - Ipsen UK
Ipsen Inc. | Aviation Pros
Ipsen to acquire Albireo accelerating growth in rare disease with treatments for several pediatric liver diseases
Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership
Ipsen Goes All In on Neuro with $1 Billion+ Deal For Exicure's Oligonucleotides | BioSpace
Ipsen CEO David Loew is elected to EFPIA leadership; joins industry partners to warn of impact of EU pharma legislation - Global
Gebrüder Weiss takes over Ipsen Logistics' Air & Sea business | DC Velocity
Press Releases - Ipsen UK
Press Releases - Ipsen UK
Ipsen NHS Study Published - IFOPA - International Fibrodysplasia Ossificans Progressiva Association
FOP Fnd NL on X: "Ipsen Initiates Partial Clinical Hold for Palovarotene IND120181 and IND135403 Studies ...for children under the age of 14 because of some cases with early growth plate closure...
Ipsen (@IpsenGroup) / X
Press Releases / Melissa Peebles
Merrimack Provides Ipsen Report That Onivyde® Regimen Demonstrated Statistically Significant Improvement in Overall Survival in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Press releases
Press Releases - Ipsen UK
Ipsen's quick fix backfires | Evaluate
Mayoly Spindler completed the acquisition of Ipsen's CHC branch - MAYOLY SPINDLER laboratoire indépendant français
Ipsen to acquire exclusive rights to investigational ERK inhibitor as part of its existing research collaboration with AGV Discovery | Liberi Group
Ipsen puts patients first
Press Releases - Ipsen UK
Global Biopharmaceutical Company, Ipsen Announces New Headquarters for North America will be located in Cambridge, Massachusetts | Financial Post
Ipsen: a dynamic, fast-growing specialty care powerhouse
Ipsen: Patients Living with Spasticity Want Long-lasting Symptom Relief | Business Wire
Ipsen ships 18 furnaces in Q2, including 210,000-pound capacity vacuum furnace | ASM International
Ipsen media library
